Hem › Alopecia areata › Texas
Kliniska studier för Alopecia areata i Texas
7 studier för Alopecia areata söker deltagare vid platser i Texas.
Städer i Texas
Officiell studietext (engelska)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- 3A Research - East location /ID# 283404, El Paso
- Texas Dermatology and Laser Specialists /ID# 282813, San Antonio
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio
RekryterarFas 2
Ålder 18 till 50 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- The University of Texas Health Science Center at Houston, Bellaire
- Center for Clinical Studies, Houston
- Center for Clinical Studies - Clear Lake, Webster
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Center for Clinical Studies, LTD. LLP, Houston
- Texas Dermatology and Laser Specialists, San Antonio
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 10 sep. 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Arlington Research Center, Inc /ID# 258028, Arlington
- Bellaire Dermatology Associates /ID# 259360, Bellaire
- Dfw Clinical Trials /ID# 284604, Carrollton
- och 5 fler
RekryterarFas 3
Ålder 12 till 63 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- 3A Research, El Paso
- Texas Dermatology and Laser Specialists, San Antonio
RekryterarFas 3
Ålder 6 till 14 · Alla kön · Uppdaterad 28 apr. 2026 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Dermatology Treatment And Research Center - Dallas, Dallas
- North Texas Center For Clinical Research, Frisco
- Austin Institute For Clinical Research Inc., Pflugerville
- och 1 fler
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 28 jan. 2026 · NCT07133308Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.